Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized, double-blind, placebo-controlled trial of pilagrel sodium injection in acute ischemic stroke
CTR20231309Phase 3Active
- Sponsor
- Hefei Yigong Pharmaceutical
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pilagrel in brain infarction, sponsored by Hefei Yigong Pharmaceutical. Started Aug 2023; status: active.
02
Drugs
pilagrel
03
Conditions
brain infarction
Beyond the preview
Go deeper on CTR20231309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231309.